Genflow Biosciences Plc (GENFF)

$0.03 -0.01 (-30.23%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 10,000
Avg Vol 67,250
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 22%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases. Its lead drug candidate is GF-1002, a suspension of an adeno...

Industry: Biotechnology
Sector: Healthcare
Address:
6 Heddon Street, London, United Kingdom
Prash83
Prash83 May. 1 at 7:45 PM
$MBOT and $GENFF Future of robotics intervention and longevity
1 · Reply
Northeast14
Northeast14 Apr. 29 at 7:07 PM
$GENFF The SLAB study remains ongoing, with all dogs continuing to be actively monitored and evaluated. The trial is expected to continue for a further four months, with completion anticipated at the end of July 2026. Additional analyses, including methylation clock (biological age) assessment and muscle histology, are in progress and are expected to provide further mechanistic and quantitative insight into the therapy's impact
0 · Reply
Northeast14
Northeast14 Apr. 20 at 8:21 PM
$GENFF you ain’t seen nothing yet!
0 · Reply
Prash83
Prash83 Apr. 20 at 5:57 PM
$GENFF $PLUG $MIRA all going good today $MBOT now your turn
1 · Reply
Northeast14
Northeast14 Mar. 5 at 12:33 PM
$GENFF Genflow Biosciences ($GENF $GENFF) has raised £800,000 through a subscription of new ordinary shares, strengthening its balance sheet and supporting continued progress across its gene therapy programs
0 · Reply
Northeast14
Northeast14 Mar. 2 at 2:32 PM
$GENFF grant funding landed today! Another great step for the company
0 · Reply
Northeast14
Northeast14 Feb. 26 at 12:17 PM
$GENFF https://x.com/genflowbioir/status/2026711382507368795?s=46
0 · Reply
Northeast14
Northeast14 Feb. 23 at 8:21 PM
$GENFF if your not in now trust me soon will be to late
0 · Reply
Northeast14
Northeast14 Feb. 16 at 6:47 PM
$DRMA look at $GENFF HUGE results last week with dog longevity trials. Away to start human trials next year
0 · Reply
Northeast14
Northeast14 Feb. 15 at 2:56 PM
$GENFF https://youtu.be/_vNmUI0qA10?si=5JQsZWTUjdhU3-un
0 · Reply
Latest News on GENFF
No data available.
Prash83
Prash83 May. 1 at 7:45 PM
$MBOT and $GENFF Future of robotics intervention and longevity
1 · Reply
Northeast14
Northeast14 Apr. 29 at 7:07 PM
$GENFF The SLAB study remains ongoing, with all dogs continuing to be actively monitored and evaluated. The trial is expected to continue for a further four months, with completion anticipated at the end of July 2026. Additional analyses, including methylation clock (biological age) assessment and muscle histology, are in progress and are expected to provide further mechanistic and quantitative insight into the therapy's impact
0 · Reply
Northeast14
Northeast14 Apr. 20 at 8:21 PM
$GENFF you ain’t seen nothing yet!
0 · Reply
Prash83
Prash83 Apr. 20 at 5:57 PM
$GENFF $PLUG $MIRA all going good today $MBOT now your turn
1 · Reply
Northeast14
Northeast14 Mar. 5 at 12:33 PM
$GENFF Genflow Biosciences ($GENF $GENFF) has raised £800,000 through a subscription of new ordinary shares, strengthening its balance sheet and supporting continued progress across its gene therapy programs
0 · Reply
Northeast14
Northeast14 Mar. 2 at 2:32 PM
$GENFF grant funding landed today! Another great step for the company
0 · Reply
Northeast14
Northeast14 Feb. 26 at 12:17 PM
$GENFF https://x.com/genflowbioir/status/2026711382507368795?s=46
0 · Reply
Northeast14
Northeast14 Feb. 23 at 8:21 PM
$GENFF if your not in now trust me soon will be to late
0 · Reply
Northeast14
Northeast14 Feb. 16 at 6:47 PM
$DRMA look at $GENFF HUGE results last week with dog longevity trials. Away to start human trials next year
0 · Reply
Northeast14
Northeast14 Feb. 15 at 2:56 PM
$GENFF https://youtu.be/_vNmUI0qA10?si=5JQsZWTUjdhU3-un
0 · Reply
IdiotCrashers
IdiotCrashers Jan. 4 at 3:54 PM
$GENFF $SRXH Dude been married to $GENFF since 2024 Wow! Enjoying .03 cent? Or deep red? You sure know how to pickem!! Follow this guru everyone!! You’ll be rich!! Whata fckn idiot loser!
0 · Reply
IdiotCrashers
IdiotCrashers Jan. 4 at 3:43 PM
$SRXH dude you have a .03 cent $GENFF OTC stock as part of your ST profile and username !! This says it all!! Go back to the iHub breakout boards amateur and DD some sub penny stocks . The fact that this stock attracts investors like you says alot about this stock! We know you used to buying a 1 million shares for .00001 cent
0 · Reply
Northeast14
Northeast14 Jan. 2 at 4:39 PM
$GENFF
0 · Reply
Northeast14
Northeast14 Jan. 2 at 12:54 PM
$SRXH anyone in any other heavily undervalued stocks? My one is $GENFF a huge sleeping giant
0 · Reply
Northeast14
Northeast14 Jan. 2 at 11:39 AM
$GENFF currently up 6% in the UK
0 · Reply
Northeast14
Northeast14 Jan. 1 at 11:37 PM
$GENFF
0 · Reply
Northeast14
Northeast14 Jan. 1 at 11:36 PM
$GENFF
0 · Reply
Northeast14
Northeast14 Jan. 1 at 6:35 PM
@incipit $GENFF will be the star of 2026. Seriously undervalued
0 · Reply
Northeast14
Northeast14 Jan. 1 at 12:56 PM
$GENFF grant money due in next week! Dog trial results Q1. Big year ahead
0 · Reply
Northeast14
Northeast14 Jan. 1 at 12:33 AM
@Donna_Ai buy $GENFF make yourself even richer in 2026
1 · Reply
Northeast14
Northeast14 Jan. 1 at 12:12 AM
$MCRB it’s $GENFF where serious gains could be had there’s no free float as it’s all is the UK
0 · Reply
Northeast14
Northeast14 Jan. 1 at 12:11 AM
$AXSM it’s $GENFF where serious gains could be had there’s no free float as it’s all is the UK. 2026 will be huge for this undervalued stock
0 · Reply